Amanote Research
Register
Sign In
Discovery of Potent, Orally-Active, and Muscle-Selective Androgen Receptor Modulators Based on an N-Aryl-Hydroxybicyclohydantoin Scaffold
doi 10.1021/jm061101w.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Discovery of an Orally-Active Nonsteroidal Androgen Receptor Pure Antagonist and the Structure–Activity Relationships of Its Derivatives
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
Myoanabolic Steroids and Selective Androgen Receptor Modulators: Mechanism of Action and Perspectives
Orvosi Hetilap
Medicine
Potent, Selective, and Orally Efficacious Antagonists of Melanin-Concentrating Hormone Receptor 1
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable Γ-Secretase Inhibitor
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
Expanding the Therapeutic Use of Androgens via Selective Androgen Receptor Modulators (SARMs)
Drug Discovery Today
Drug Discovery
Pharmacology
Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors
The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
Current Clinical Pharmacology
Medicine
Toxicology
Pharmaceutics
Pharmacology
Selective Estrogen Receptor Modulators